IL6 and type 2 diabetes mellitus: Izaguirre et al. [2] reported that the use of exendin-4 upregulated the mRNA levels of ADIPOQ and downregulated the expression of IL-1B, IL-6, IL-8, and TNF genes in the visceral adipocytes of patients with T2DM.